Alishan Naqvee brings extensive experience across his diverse and well-established practice areas. He offers comprehensive, one-stop legal solutions tailored to their legal and business needs of the clients. His equally strong foundation in the areas of commercial laws, commercial transactions and disputes has shaped his strategic vision, enabling him to deliver practical and result-oriented advice across his practice areas.

Alishan is recognized as a company law expert for his deep understanding of Indian company and regulatory frameworks. Alishan has successfully represented many multinational corporations, Indian corporates, venture capital funds and high net worth individuals in various sectors of economy and disputes resolution. His experience includes transactions across all sectors of economy, acquisitions and mergers, cross-border investments, tax and policy benefits.

Alishan is one of the leading litigation and arbitration experts in India, heading the Firm’s well-established disputes resolution practice across Indian courts and tribunals at all levels. As an arguing counsel, he is regularly briefed and has appeared before most courts and tribunals in Delhi NCR and several jurisdictions across India. He has represented prominent clients such as Coca-Cola, Carlsberg India Private Limited, Indus Motors, Exchange4Media Group, Business World, and several others in complex commercial and regulatory disputes. In addition, Alishan has extensive experience in both domestic and international arbitration. Having represented clients including SKF India Group, Depa LLC and SSIPL Group in high-value domestic and international arbitration proceedings before institutional and ad hoc tribunals.

Alishan is an expert in Pharma and Healthcare laws. He is considered an authority in India in the areas of biotechnology, MedTech and healthcare, having advised clients such as Pfizer, Takeda Pharmaceutical Company Limited, Boston Scientific, Biogen Idec, IQVIA, Medanta Duke Research Institute, Memorial Sloan Kettering Cancer Centre, Stanford Health Care, New York University School of Medicine, Apple Inc., Verily, Farcast Biosciences, Goldfinch Bio, and Lumenis on a wide range of matters including clinical research and trials, regulatory and ethical compliance under the Drugs and Cosmetics Act and Medical Devices Rules, AI tools in the healthcare sector, export and use of biospecimens, and data protection in health research. He has also represented the Indian Society of Clinical Research before the Supreme Court of India in Swasthya Adhikar Manch, Indore & Anr. vs. Union of India and served on expert committees reviewing the ICMR’s Ethics Guidelines for Biomedical Research.

Alishan has consistently been nominated as a “Leading Lawyer in India” in his areas of practice. Under his leadership, LexCounsel’s dispute resolution, as also insolvency and bankruptcy practices, have won reputed awards as one among the best in India. LexCounsel is also the winner of BW Business World Institutional Excellence Award in Healthcare Legal Services.